RPL554 »

  • Accendo Markets

    Verona Pharma is developing first-in-class drugs to treat respiratory disease, such as COPD and asthma. The Company currently has two drug programmes, one of which is in Phase II trials for two diseases with the other being in Phase I. The company is Cardiff, UK based. Price 1.20GBp Market cap £12.12m Source: wall street journal